Related Experiment Videos
[Atrial natriuretic factor in congenital heart defects in infants]
L Cekovský1, I Lazúrová, M Herichová
1IV. Detská klinika IVZ pri Detskej nemocnici, Kosice.
Insights
Infants with inborn heart disease showed higher levels of atrio-natriuretic factor (ANF) compared to healthy infants. This finding may help in diagnosing congenital heart conditions in newborns.
Area of Science:
- Cardiology
- Pediatrics
- Biochemistry
Context:
- Congenital heart disease is a significant concern in infants.
- Accurate diagnosis is crucial for timely intervention.
- Atrio-natriuretic factor (ANF) is a hormone with implications in cardiovascular function.
Purpose:
- To investigate the levels of atrio-natriuretic factor (ANF) in infants diagnosed with inborn heart disease.
- To compare ANF levels in infants with congenital heart disease against a control group of healthy infants.
Summary:
- This study measured atrio-natriuretic factor (ANF) levels in a small cohort of 7 infants with inborn heart disease (age 3 weeks to 5.5 months).
- A control group of 9 convalescent infants (age 1-10 months) was also studied.
- Congenital heart disease was confirmed using clinical methods (ECG, X-ray) and advanced echocardiography.
- Results indicated elevated ANF levels in infants with inborn heart disease compared to the control group.
Impact:
- The findings suggest that elevated ANF may serve as a potential biomarker for inborn heart disease in infants.
- This research could contribute to improved diagnostic approaches for congenital heart conditions.
- Further research with larger cohorts is warranted to validate ANF's role in pediatric cardiology.
Abstract:
The authors examined the level of the atrio-natriuretic factor (ANF) in 7 infants with inborn heart disease at the age of 3 weeks to 5.5 months. As controls they examined 9 convalescent infants aged 1-10 months. Congenital heart disease was confirmed by clinical methods (ECG and X-ray) and echocardiographically (one-dimensional, two-dimensional and pulsed Doppler echocardiography, 5MHz probe, Kontron Co.). Although a small group is involved, elevated ANF values were recorded in infants with inborn heart disease, as compared with controls.